COHERUS BIOSCIENCES INC stock forecast: up to 6.76 USD CHRS stock price prognosis

STOCK

Forecast for Fri 26 May 2023 price 7.11

COHERUS BIOSCIENCES INC stock price forecast for further price development up to 5.10% (time horizon: 1 day) and price target of 6.76 USD. Positive news sentiment. Short-term (time horizon: 2 weeks) COHERUS BIOSCIENCES INC share price prediction for 2023-05-26 with daily closed price projections

Key Facts

Symbol CHRS

ISIN US19249H1032

CUSIP 19249H103

Currency USD

Category Biological Products (No Diagnostic Substances)

Forecast price change %

News sentiment (0.71)

News <--> Close correlation for next day influence (-0.16)

Finance numbers

Revenue 442,678,000.0

Earnings per share -1.23

On our site we made daily predictions for finance products based on statistical analysis. You can export / download forecasted data as CSV file, no login required. The information can be used for day trading.

Summerized Form 10-K with GPT-2

Both supplemental NDAs received priority review designations from the NMPA in July 2020. In November 2018, we extended our partnership with KBI until December 31, 2023. Any legal and regulatory changes may impact our operations in the future. An IND must become effective before U.S. clinical trials may begin. The CCPA and the CPRA may increase our compliance costs and potential liability. We believe we have good relations with our employees. We completed the initial public offering of our common stock in November 2014. We continue to be dependent on the ability to raise funding. As of December 31, 2020, we had 317 employees. CROs may also generate higher costs than anticipated. On October 11, 2019, we filed a Motion for Attorneys' Fees with the District Court. Third parties may request an IPR of our patents in the USPTO. 6.Simultaneous Exchange of Patents. We currently do not have any approved products, other than UDENYCA®. The BPCIA established this abbreviated pathway under section 351(k) of the PHSA. Moreover, market acceptance of biosimilar products in the United States is unclear. In addition, there may be other efforts to challenge, repeal or replace the ACA.

Summerized Form 10-K with GPT-2 https://www.sec.gov/Archives/edgar/data/1512762/000155837021001829/0001558370-21-001829.txt

Candlestick patterns

Candlestick patterns can be used as additional information for price prediction. Following list show which pattern applies on latest price information.

Meta analyst score 43.40/100

Institutional ownership list is based on filling form information

Holding name	Date	Amount
American Portfolios Advisors	2022-06-30	1576
American Portfolios Advisors	2021-12-31	1576
American Portfolios Advisors	2022-03-31	1576
American Portfolios Advisors	2022-09-30	1576
A - VOYA INVESTMENT MANAGEMENT LLC	2022-09-30	297115

Fund ownership list is based on filling form information

Fund name	Date	Amount	Profile
Bernstein Fund Inc	2022-12-31	122049	Long
SPDR SERIES TRUST	2022-12-31	159381	Long
STATE STREET INSTITUTIONAL INVESTMENT TRUST	2022-12-31	22517	Long
SPDR SERIES TRUST	2022-12-31	4533431	Long
SPDR SERIES TRUST	2022-12-31	335931	Long

Assets / Liabilities

Bollinger Bollinger Bands for COHERUS BIOSCIENCES INC can provide the information where the market is moving based on price information.

COHERUS BIOSCIENCES INC Short Volume Ratio is shown in the diagram. Short volume sales can be seen as an investor sentiment.

Converting prices to returns COHERUS BIOSCIENCES INC.

On-Balance Volume information for COHERUS BIOSCIENCES INC. On-Balance Volume information can be an indicator for bullish or bearish outcome.

Accumulation / Distribution (A/D) indicator information for COHERUS BIOSCIENCES INC. The indicator identify divergences between price and volume flow.

Aroon Oscillator information for COHERUS BIOSCIENCES INC. The trend-following indicator can show the strengh of a current trend and likelihood that trend can continue.

Average Directional Index (ADX) information for COHERUS BIOSCIENCES INC. The index can be used to identify the strengh of a trend.

Moving Average Convergence Divergence (MACD) for COHERUS BIOSCIENCES INC. The indicator helps to predict trend direction and the momentum of the trend.

Stochastic Oscillator as momentum indicator for COHERUS BIOSCIENCES INC. The indicator is useful for identifying overbought and oversold levels.

Relative Strength Index (RSI) for COHERUS BIOSCIENCES INC. RSI is a momentum oscillator that measures the speed and change of price development. The momentum indicator was created by analyst Welles Wilder. The result compares recent gains and losses over restricted time period. Primary usage of the indicator is to identify overbought or oversold signals. When RSI indicator reaches a value of 70 it could mean that speculators should consider selling, suggests Wilder and Chong. Or vice versa when selling excess at which the RSI Indicators show a value of 30 [ Relative Strength Index for Developing Effective Trading Strategies in Constructing Optimal Portfolio ].

52W High	52W Low	Market Cap

Similar shares

Trend:

Codiak BioSciences, Inc

Trend:

NOVAVAX INC

News sentiment

Trend:

TITAN PHARMACEUTICALS INC

Trend:

KODIAK SCIENCES INC

COHERUS BIOSCIENCES INC on Nasdaq

COHERUS BIOSCIENCES INC on finviz

Figure below show the stock predictions.

Date	Closing price	Prediction was updated
2023-04-27	6.76	2023-03-31 06:53
2023-05-02	6.81	2023-03-31 06:53
2023-04-28	6.78	2023-03-31 06:53
2023-05-01	6.79	2023-03-31 06:53
2023-05-03	6.82	2023-03-31 06:53
2023-05-04	6.84	2023-03-31 06:53
2023-05-05	6.86	2023-03-31 06:53
2023-05-08	6.88	2023-03-31 06:53
2023-05-09	6.90	2023-03-31 06:53
2023-05-10	6.92	2023-03-31 06:53
2023-05-11	6.93	2023-03-31 06:53
2023-05-12	6.95	2023-03-31 06:53
2023-05-17	7.00	2023-03-31 06:53
2023-05-18	7.01	2023-03-31 06:53
2023-05-25	7.10	2023-03-31 06:53
2023-05-22	7.05	2023-03-31 06:53
2023-05-23	7.06	2023-03-31 06:53
2023-05-15	6.96	2023-03-31 06:53
2023-05-16	6.98	2023-03-31 06:53
2023-05-19	7.03	2023-03-31 06:53
2023-05-24	7.08	2023-03-31 06:53
2023-05-26	7.11	2023-03-31 06:53
2023-04-03	6.48	2023-03-31 06:53
2023-04-04	6.51	2023-03-31 06:53
2023-04-05	6.46	2023-03-31 06:53
2023-04-06	6.45	2023-03-31 06:53
2023-04-07	6.48	2023-03-31 06:53
2023-04-12	6.61	2023-03-31 06:53
2023-04-13	6.60	2023-03-31 06:53
2023-04-14	6.62	2023-03-31 06:53
2023-04-17	6.63	2023-03-31 06:53
2023-04-18	6.63	2023-03-31 06:53
2023-04-19	6.64	2023-03-31 06:53
2023-04-20	6.65	2023-03-31 06:53
2023-04-10	6.54	2023-03-31 06:53
2023-04-11	6.59	2023-03-31 06:53
2023-04-21	6.67	2023-03-31 06:53
2023-04-24	6.69	2023-03-31 06:53
2023-04-25	6.73	2023-03-31 06:53
2023-04-26	6.74	2023-03-31 06:53

The forecast (dashed curve) of the share price performance is based on historical data. Our forecast model is based on mathematical, statistical methods. The website offers price forecasts and analysis tools for equities and other securities, which are exclusively based on the prices of these securities in the past. Information about these prices is provided to us by third parties. Although we believe, If we believe that our sources are reliable, we cannot guarantee the accuracy, completeness, timeliness and correct sequencing of this information. We do not investigate the issuers of the securities to which our forecasts relate, nor do we consider any financial data or other data of such issuers with the exception of the past prices of the securities. Therefore, our forecasts do not constitute an analysis of other commercial or financial factors or circumstances, that may be relevant for future security price flows. Investments require additional considerations. Our forecasts cannot reflect the specific situation. Experience and risk profile of an individual investor or the tax implications an investment may have for the investor. Although we believe that our mathematical models are a tool to try to explore the possibility for future price development with the help of past performance, such developments are subject to a multitude of different influences. and therefore not really predictable. We cannot guarantee the success of any investment you make based on the information published here. This website is for information purposes only. All information and data on this website cannot be guaranteed to be accurate, accuracy, completeness and appropriateness - neither explicit nor implicit.